WANDA BEARING
920002
HENDERA
831152
LINGOOD
833284
4
WUHAN LAND
830779
5
TECHVISION
832876
US Stock MarketDetailed Quotes
KROS Keros Therapeutics
- 10.940
- +0.035+0.32%
Close Feb 26 16:00 ET
443.15MMarket Cap-2.10P/E (TTM)
11.180High10.790Low1.49MVolume10.940Open10.905Pre Close16.29MTurnover4.22%Turnover RatioLossP/E (Static)40.51MShares72.37052wk High0.83P/B386.96MFloat Cap9.77552wk Low--Dividend TTM35.37MShs Float88.800Historical High--Div YieldTTM3.58%Amplitude9.775Historical Low10.920Avg Price1Lot Size
Keros Therapeutics Key Stats
EPS
According to the latest financial report of Keros Therapeutics, the latest earnings per share (TTM) for the company is -1.14. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Keros Therapeutics's free cash flow? The latest report shows it as -46.30M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Keros Therapeutics shows that the company's current ratio is 19.03, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Keros Therapeutics, the quick ratio is 18.36, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Keros Therapeutics? The latest ROE figure is -11.10%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Keros Therapeutics, the total asset return on investment (ROA) is -10.24%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Keros Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Keros Therapeutics, the net profit margin is -1.51K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!